A carregar...
New strategies in HER2-overexpressing breast cancer: Many combinations of targeted drugs available
The anti-HER2 drugs trastuzumab and lapatinib are increasingly changing the natural history of early and metastatic HER2-overexpressing breast cancer. Many other agents targeted against the HER2 signaling network are in clinical development. These are or will soon be combined with the currently appr...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3761872/ https://ncbi.nlm.nih.gov/pubmed/21248299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1947 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|